Apricus Biosciences Inc (NASDAQ:APRI)

0.4845
Delayed Data
As of Jun 19
 +0.1292 / +36.36%
Today’s Change
0.25
Today|||52-Week Range
3.34
-73.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$6.8M

Company Description

Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA.

Contact Information

Apricus Biosciences, Inc.
11975 El Camino Real
San Diego California 92130
P:(858) 222-8041
Investor Relations:

Employees

Shareholders

Individual stakeholders8.78%
Other institutional27.89%
Mutual fund holders2.51%

Top Executives

Richard W. PascoeCEO, CFO, CAO, Secretary & Director
Neil C. MortonChief Business Officer & Senior Vice President
Brian T. DorseyChief Development Officer & Senior Vice President
Mary NaggsGeneral Counsel & Vice President